why choose us

First received: June 08, 2023

Clinical Trial: A Study to Investigate the Safety, Immunogenicity of a Bivalent mRNA Vaccine RQ3025 as a Booster Dose in Healthy Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: An Interventional, Randomized, Parallel Controlled, Investigator Initiated Study to Investigate the Safety, Immunogenicity of a Bivalent RQ3025 mRNA Vaccine as a Booster Dose in 3 Doses COVID-19 Vacci

Brief Summary: This clinical trial aimed to gather safety and immunogenicity data in COVID-19 vaccine-experienced healthy adults.The main questions it aims to answer are:The neutralizing antibodies levels of bivalent mRNA vaccines RQ3025(Alpha/Beta+Omicron BA.2/4/5) and monovalent mRNA vaccine RQ3013 against the current SARS-CoV-2 circulating variant.The safety profile of RQ3025 given as a second booster dose to COVID-19 vaccine-experienced participants 18 through 55 years of age.Explore the protective efficacy by…

Read more